FDA Warning Letter — Hubei Danao Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Hubei Danao Pharmaceutical Co., Ltd. on November 6, 2017 (Shiyan, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Hubei Danao Pharmaceutical Co., Ltd.
- Date
- November 6, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Shiyan (China)